Results

Total Results: 386 records

Showing results for "venous thromboembolism".
Users also searched for: vte

  1. www.ahrq.gov/hai/pfp/interimhac2014-ap1.html
    November 01, 2015 - Saving Lives and Saving Money: Hospital-Acquired Conditions Update Appendix: Incidence of Hospital-Acquired Conditions in the Partnership for Patients: Estimates and Projected and Measured Impact Previous Page   Table of Contents Saving Lives and Saving Money: Hospital-Acquired Conditions Update …
  2. www.ahrq.gov/research/findings/evidence-based-reports/search.html?page=42
    February 01, 2001 - Evidence Reports Affiliation: McMaster University Report Status: Final Prevention of VenousThromboembolism After Injury Report Type: Evidence Reports Affiliation: Southern California EPC—RAND
  3. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patientsafetyculture/asc/ascwebinar/battlesslides.pdf
    July 18, 2015 - is significant variability across outpatient surgery facilities in the rates of (2015):  30-day venousthromboembolism (0-3.4%)  30-day admission rates (0-7.7%)  30-day emergency department visits
  4. www.ahrq.gov/sites/default/files/wysiwyg/npsd/Data_Submission_Dashboard_Data_2019.xlsx
    January 01, 2019 - Healthcare-associated Infection CFER-H V1.1 1,557 0.6% Healthcare-associated Infection CFER-H V1.2 8,653 1.0% VenousThromboembolism CFER-H V1.2 201 0.0% NOTE: Percentage sums to 100% within each 'Version'
  5. www.ahrq.gov/news/newsroom/case-studies/ktcquips73.html
    October 01, 2014 - and provider support calls for implementing the AHRQ-funded toolkit, Preventing Hospital-Acquired VenousThromboembolism: A Guide for Effective Quality Improvement . … recommended in the VTE toolkit. … daily monitoring of VTE risk assessment became amazingly clear. … to an increase in VTE prophylaxis orders.
  6. www.ahrq.gov/news/newsroom/case-studies/ktcquips74.html
    October 01, 2014 - and provider support calls for implementing the AHRQ-funded toolkit, Preventing Hospital-Acquired VenousThromboembolism: A Guide for Effective Quality Improvement . … Case studies revealed that one patient would have benefited from VTE prophylaxis." … the VTE toolkit. … protocol to be consistent with the VTE toolkit.
  7. www.ahrq.gov/sites/default/files/publications2/files/interimhacrate2014_cx.pdf
    November 19, 2015 - Saving Lives and Saving Money: Hospital-Acquired Conditions Update - Interim Data From National Efforts To Make Care Safer, 2010-2014 Saving Lives and Saving Money: Hospital-Acquired Conditions Update Interim Data From National Efforts To Make Care Safer, 2010-2014 Summary Interim estimates for 2014 show a sust…
  8. www.ahrq.gov/sites/default/files/publications/files/interimhacrate2014_2.pdf
    November 19, 2015 - Saving Lives and Saving Money: Hospital-Acquired Conditions Update - Interim Data From National Efforts To Make Care Safer, 2010-2014 Saving Lives and Saving Money: Hospital-Acquired Conditions Update Interim Data From National Efforts To Make Care Safer, 2010-2014 Summary Interim estimates for 2014 show a s…
  9. www.ahrq.gov/research/findings/studies/index.html?page=110
    January 01, 2024 - Among patients with AF but without acute venous thromboembolism, those who received an inappropriate … thromboembolism in US adults. … Patients with certain inflammatory skin diseases have multiple risk factors for venous thromboembolism … (VTE). … Association of inflammatory skin diseases with venous thromboembolism in US adults.
  10. www.ahrq.gov/research/findings/evidence-based-reports/search.html?page=29
    October 01, 2009 - Chapel Hill Report Status: Final Outcomes of Genetic Testing in Adults with a History of VenousThromboembolism Date: June 2009 Report Type: Evidence Reports Affiliation: Johns Hopkins University
  11. www.ahrq.gov/research/findings/studies/index.html?page=267
    January 01, 2024 - Fleming KI , Agarwal J The impact of once- versus twice-daily enoxaparin prophylaxis on risk for venousthromboembolism and clinically relevant bleeding. … This study compared pharmacodynamic and clinical outcomes, including 90-day venous thromboembolism and … thromboembolism risk reduction. … The impact of once- versus twice-daily enoxaparin prophylaxis on risk for venous thromboembolism and
  12. www.ahrq.gov/hai/pfp/interimhac2013-ap1.html
    December 01, 2014 - Efforts To Improve Patient Safety Result in 1.3 Million Fewer Patient Harms Appendix Previous Page Next Page Table of Contents Efforts To Improve Patient Safety Result in 1.3 Million Fewer Patient Harms Appendix References Exhibit A1: 2013 Interim AHRQ National Scorecard Data o…
  13. www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/quality-measures/qsrs/qsrs-2021-2022-adverse-event-data-report.pdf
    January 01, 2022 - Thromboembolism (VTE) 2.92.6 Other AEs 1.71.5 Blood or Blood Product 1.60.6 Birth – Maternal 0.0 … Venous Thromboembolism (VTE) Deep vein thrombosis (DVT) without pulmonary embolism (PE) PE without … Thromboembolism (VTE) 7 3373 0.2 0.1 – 0.4 58 18276 0.3 0.3 – 0.4 Deep vein thrombosis ( … At Risk AE Rate (%) 95% CI Venous Thromboembolism (VTE) 29 11746 0.3 0.2 – 0.4 36 9903 0.4 … Thromboembolism (VTE) 14 3719 0.4 0.2 – 0.6 55 21670 0.3 0.2 – 0.3 Deep vein thrombosis
  14. www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/quality-measures/qsrs/qsrs-2021-2022-adverse-event-data-report-oct-rev.pdf
    January 01, 2022 - Thromboembolism (VTE) 2.92.6 Other AEs 1.71.5 Blood or Blood Product 1.60.6 Birth – Maternal 0.0 … Venous Thromboembolism (VTE) Deep vein thrombosis (DVT) without pulmonary embolism (PE) PE without … Thromboembolism (VTE) 7 3373 0.2 0.1 – 0.4 58 18276 0.3 0.3 – 0.4 Deep vein thrombosis ( … At Risk AE Rate (%) 95% CI Venous Thromboembolism (VTE) 29 11746 0.3 0.2 – 0.4 36 9903 0.4 … Thromboembolism (VTE) 14 3719 0.4 0.2 – 0.6 55 21670 0.3 0.2 – 0.3 Deep vein thrombosis
  15. www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/quality-measures/qsrs/qsrs-2021-2022-adverse-event-data-report-nov-rev.pdf
    January 01, 2022 - Thromboembolism (VTE) 2.92.6 Other AEs 1.71.5 Blood or Blood Product 1.60.6 Birth – Maternal 0.0 … Venous Thromboembolism (VTE) Deep vein thrombosis (DVT) without pulmonary embolism (PE) PE without … Thromboembolism (VTE) 7 3373 0.2 0.1 – 0.4 58 18276 0.3 0.3 – 0.4 Deep vein thrombosis ( … At Risk AE Rate (%) 95% CI Venous Thromboembolism (VTE) 29 11746 0.3 0.2 – 0.4 36 9903 0.4 … Thromboembolism (VTE) 14 3719 0.4 0.2 – 0.6 55 21670 0.3 0.2 – 0.3 Deep vein thrombosis
  16. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/updatedhacrateinfo.pdf
    June 01, 2014 - 82,000 2.51 82,000 2.51 VAP MPSMS Ventilator-Associated Pneumonia 35,000 1.07 34,000 1.02 VTE
  17. www.ahrq.gov/research/findings/studies/index.html?page=463
    January 01, 2024 - , Influenza Ju MH , Chung JW , Kinnier CV Association between hospital imaging use and venousthromboembolism events rates based on clinical data. … This study assessed the presence and extent of venous thromboembolism (VTE) surveillance bias using high-quality … have increased vigilance for VTE by performing more VTE imaging studies that result in higher VTE event … Association between hospital imaging use and venous thromboembolism events rates based on clinical data
  18. www.ahrq.gov/sites/default/files/wysiwyg/npsd/Data_Submission_Dashboard_Data_2024.xlsx
    January 01, 2024 - Healthcare-Associated Infection CFER-H V1.1 1,557 0.6% Healthcare-Associated Infection CFER-H V1.2 17,405 0.7% VenousThromboembolism CFER-H V1.2 247 0.0% NOTE: Percentage sums to 100% within each 'Version'
  19. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/Updated-hacreportFInal2017data.pdf
    July 01, 2020 - Infection NHSN SSIs for 17 procedures w/CDC SCIP+5 data VAP MPSMS Ventilator-Associated Pneumonia VTE … 2.67 VAP MPSMS Ventilator- Associated 35,894 1.21 27,548 0.93 25,695 0.86 31,213 1.05 Pneumonia VTE … $22,898 0.026 (0.009–0.059) 0.028 VAP $47,238 ($21,890–$72,587) $22,898 0.140 (-0.110–0.730) 0.144 VTE
  20. www.ahrq.gov/sites/default/files/2024-02/king-report.pdf
    January 01, 2024 - Temporal trends in first-line anticoagulation therapy for cancer-associated venous thromboembolism. … P5590 Temporal trends in first line anticoagulation therapy for cancer-associated venous thromboembolism … P5239 Cost-effectiveness of direct oral anticoagulants for cancer-associated venous thromboembolism.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: